Skip to main content
. Author manuscript; available in PMC: 2011 Mar 1.
Published in final edited form as: Cancer Causes Control. 2009 Nov 28;21(3):445–461. doi: 10.1007/s10552-009-9476-y

Table 1.

Use of endoscopy in 2000–2005 by sample cohort of well-insured persons (cohort aged 65+ in the year 2000, followed through 2005)

State Sample size in state Proportion with any use in 2000–2002 Proportion with any use in 2003–2005 but not 2000–2002 Proportion with any use in both periods Proportion with any use in 2000–2005
CA 86,843 0.31 0.23 0.14 0.47
CT 23,402 0.36 0.27 0.17 0.53
GA 10,316 0.37 0.26 0.17 0.53
IA 22,799 0.38 0.24 0.19 0.53
KY 18,203 0.32 0.23 0.15 0.47
LA 15,717 0.29 0.23 0.14 0.46
MI 25,692 0.37 0.25 0.19 0.53
NJ 35,378 0.33 0.23 0.17 0.48
NM 7,439 0.30 0.21 0.14 0.45
UT 8,777 0.34 0.26 0.15 0.51
WA 17,511 0.34 0.26 0.15 0.51

We used the following codes on Medicare claims to identify endoscopy use: CPT codes: 44388–44397, 45300–45392; HCPCS codes: G0104, G0105, G0121; and ICD-9-CM codes: 45.22–45.25, 45.41–45.43, 48.22–48.24, 48.36 We used ICD-9-CM codes 555.x and 556.x listed on the Medicare claims to identify persons with IBD